Rheumatoid interstitial lung disease in Canterbury New Zealand: prevalence, risk factors and long-term outcomes—protocol for a population-based retrospective study

INTRODUCTION: Rheumatoid arthritis (RA) affects approximately 0.5%–1% of the general population. Clinically significant interstitial lung diseases (ILD) develops in just under 10% of people with RA, and subclinical disease is more common. Little is known about RA-ILD in New Zealand (NZ), or the numb...

Descripción completa

Detalles Bibliográficos
Autores principales: Farquhar, Hamish, Beckert, Lutz, Edwards, Adrienne, Matteson, Eric L., Thiessen, Rennae, Ganly, Edward, Stamp, Lisa K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Epidemiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8983996/
https://www.ncbi.nlm.nih.gov/pubmed/35383056
http://dx.doi.org/10.1136/bmjopen-2021-050934

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8983996/
https://www.ncbi.nlm.nih.gov/pubmed/35383056
http://dx.doi.org/10.1136/bmjopen-2021-050934

Ejemplares similares